What You Should Know
- The Launch: Thyme Care, a leading value-based cancer care enabler, has officially launched its Integrated Social Support (ISS) model.
- The Paradigm Shift: Instead of waiting for a patient to flag an emotional or financial crisis, Thyme Care is positioning licensed, master’s-level social workers as the first point of intervention. 100% of members are proactively screened for psychosocial barriers at enrollment.
- The Data Reality: Proactive screening at just one partner site revealed staggering non-clinical barriers: 53% of patients faced financial toxicity, 22% experienced food insecurity, and 13% had transportation barriers.
- The AI Engine: The human-led social work team is powered by a proprietary AI infrastructure that continuously synthesizes claims, clinical, and social data into a “dynamic acuity model.” This algorithm ensures the highest-risk patients are prioritized for outreach in real time.
Scaling Empathy with AI
In healthcare operations, the primary challenge with social work is scalability. How do you deploy highly trained clinical social workers (LCSWs) efficiently across a massive, geographically dispersed patient population without burning them out?
Thyme Care solves this by wrapping its human workforce in a layer of advanced data architecture. The company’s social work team is directed by an AI infrastructure that continuously ingests and synthesizes claims data, clinical records, and social determinants of health (SDOH) metrics. This data feeds a dynamic “acuity model” that triages the patient panel in real time.
Instead of working blindly through a static list of phone numbers, the technology ensures that Thyme Care’s social workers are instantly routed to the patients whose data signals an impending crisis, ensuring nobody slips through the cracks.
ISS Model Clinical and Financial ROI
When you combine intelligent tech routing with proactive human screening (utilizing validated tools like the NCCN Distress Thermometer and the Columbia Suicide Risk Assessment), the financial and clinical ROI materializes rapidly.
Since introducing ISS in late 2025, Thyme Care has scaled its team to over 40 licensed master-level social workers, making it one of the largest value-based oncology social work investments in the country. The results are undeniable:
- High-risk members engaged in symptom monitoring experience a 30% relative risk reduction in ED or inpatient events.
- Members completing discharge assessments see a 20% relative risk reduction in hospital readmissions.
- 88% of members report feeling more supported after engaging with the platform.
Once a barrier is identified, the ISS model deploys targeted interventions, ranging from virtual peer support groups and 12-week self-guided educational programs to one-on-one crisis intervention and behavioral health stabilization.
“You cannot treat cancer without addressing the emotional and social realities that come with it,” said Stephanie Broussard, DSW, LCSW-S, APHSW-C, Director of Social Work at Thyme Care. “In five years of supporting individuals with cancer, Thyme Care has continuously iterated on this belief, and what we’ve learned is that the barriers most likely to derail treatment are rarely clinical. Social workers are trained to look beyond the presenting problem and understand the why behind it, whether that’s housing instability, caregiver strain, depression, or fear about the future. There isn’t a shortage of social workers; there’s a shortage of intention. We’ve intentionally built a model that centers their expertise from the very beginning, so we can identify needs earlier and truly support the whole person.”
